Dr. Mohamed K. Khan joined the staff at Roswell Park Cancer Institute (RPCI) in 2004. He is an Attending Physician, the Director of Basic and Translational Radiation Research, co–director and founder of the NanoBiotechnology Center at RPCI, and the Residency Program Director in the Department of Radiation Medicine. He also serves as Associate Professor in the Department of Radiation Medicine at the University at Buffalo.
Dr. Khan earned his doctoral degree (PhD) in Biochemistry and Molecular Biology from the University of California–Santa Barbara in 1993. He completed his medical degree (MD) from the University of Chicago–Pritzker School of Medicine in 1994. He did his internship training in Internal Medicine and Surgery at the Newton–Wellesley Hospital, Newton, MA, and completed his residency in Radiation Oncology at Harvard's Joint Center for Radiation Therapy (Brigham and Women's Hospital, Dana Farber Cancer Institute, Boston Children's Hospital, and Beth Israel–Deaconess Medical Center) in Boston, MA. During this time he also completed a research fellowship with Dr. Judah Folkman focused on the systemic affects of radiation on angiogenesis and tumor growth through Harvard University at Children's Hospital, Boston, MA. Dr. Khan then proceeded to the University of Michigan where he treated radiation oncology patients at the Ann Arbor VA Healthcare System, and conducted basic and translational cancer research focused on tumor angiogenesis, nanotechnology, and radiation therapy at the University of Michigan Medical Center. He has greatly expanded much of this work upon coming to RPCI.
Printer-friendly version
Send to friend
